Efavirenz
- Product NDC
- 70518-1013
- 11-digit product format
- 705181013
- Labeler code
- 70518
- Product ID
- 70518-1013_8fe58da6-7f05-5781-e053-2a95a90ae2bd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- efavirenz
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA091471
- Marketing category
- ANDA
- Marketing start
- 2018-02-12
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record